Clinical Trial Update: Effect of Ginger Supplement on Non-alcoholic Fatty Liver [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating a ginger supplement for non-alcoholic fatty liver disease has completed. The study was sponsored by Dr Azita Hekmatdoost.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Ginger supplement (ginger (Zingiber officinale))

Snippet

Sponsor: Dr Azita Hekmatdoost | Conditions: Non-alcoholic Fatty Liver Disease | Phase 2, Phase 3 | Status: COMPLETED